HOME >> BIOLOGY >> NEWS
Transplant patients from 40 years ago cause Pittsburgh doctors to take an about-face

MIAMI, Aug. 26 In a radical departure from the standard way of treating transplant patients, doctors from the University of Pittsburgh's Thomas E. Starzl Transplantation Institute have gone back to the future, so to speak.

Instead of the current practice of giving patients high doses of multiple drugs to suppress the immune system as soon as the organ is transplanted, the Pittsburgh team is giving a one-time dose of a drug that depletes important immune system cells just hours before transplantation and lower-than- usual doses of just one anti-rejection drug beginning the day after transplantation. Ninety days later, if there has been no rejection, the weaning process begins.

A similar strategy, without the deliberate attempt to wean, was in place 40 years ago. Seven of nine recipients of living-donor kidney transplants from that era have been off all anti-rejection drugs for between two and one-half and 38 years. Some stopped taking the drugs on their own. Others were weaned under doctors' supervision. That clinical experience of four decades ago coupled with a modern understanding of what is required for the immune system to accept a transplanted organ without the need for immunosuppression, led to the "new" clinical approach, said Thomas E. Starzl, M.D., Ph.D., at the XIX International Congress of The Transplantation Society.

Since implementing the regimen, which aims to radically reduce and eventually wean patients off all immunosuppression, some transplant recipients of the small bowel, an organ especially prone to rejection, are taking a single anti-rejection drug and only once or twice a week, University of Pittsburgh researchers reported today. Many kidney, liver and pancreas transplant patients being treated under the new philosophy, introduced last year, are on minimal weekly doses as well.

In order to prevent rejection of the transplanted organ, doctors typically provide patients with strong immunosuppressives, often in
'"/>

Contact: Lisa Rossi
412-647-3555
University of Pittsburgh Medical Center
26-Aug-2002


Page: 1 2 3 4 5 6

Related biology news :

1. Transplant rejection averted by simple light exposure in Stanford animal study
2. Media invited to attend International Society For Heart & Lung Transplantation meeting April 21-24
3. Transplantation of embryonic pancreatic tissue controls Type 1 diabetes in rats
4. Cell Transplant Society holds 6th International Congress in Atlanta March 2-5
5. Transplantation Society Congress
6. Transplanted stem cells restore function in stroke
7. Artificial lung on the horizon, reports University of Pittsburgh researcher at International Society for Heart and Lung Transplantation meeting
8. Transplanted human stem cells develop into broad range of tissues, persist over a year in research at The Childrens Hospital of Philadelphia
9. Omaha to host International Small Bowel Transplant Symposium
10. Transplant cells show capacity for mending nervous system
11. Transplanted neural stem cells migrate throughout the abnormal brain, reduce disease symptoms

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2020)... ... 2020 , ... Nine middle school teachers from eight states ... unique professional development program that provides advanced STEM (science, technology, engineering and math) ... , Created in partnership between the National Stem Cell Foundation and The Gatton ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... Phase II contract awarded by the Joint Science & Technology Office—Chemical and Biological ... is to develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess ...
(Date:7/18/2020)... ... July 16, 2020 , ... ... effectiveness of the Invictus Medical Neoasis™ active noise control device to attenuate typical ... that the Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators and ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... , ... July 29, 2020 , ... ... Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions ... that they have entered into a strategic partnership whereby Catalent will provide support ...
(Date:7/31/2020)... (PRWEB) , ... July 30, ... ... of cloud-based software for the life sciences industry, today announced the release ... platform designed specifically for Medical Science Liaisons (MSLs) and other field medical ...
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver this ... the only technology of its kind on the market and we were pleased that ... protective capacity of traditional cultured ingredients, creating a natural way to extend the shelf ...
(Date:7/10/2020)... ... July 08, 2020 , ... Bode ... significant expansion of laboratory operations through its COVID-19 testing service, Bode-CARES . ... , Bode-CARES provides a turnkey solution that includes a comprehensive ...
Breaking Biology Technology:
Cached News: